| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Jul 22, 2013 | Sale | $12.10 | 1,000 | 12,100 | 166,860 | Jul 23, 2013, 05:10 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Jul 15, 2013 | Sale | $10.55 | 3,500 | 36,925 | 167,860 | Jul 16, 2013, 06:09 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Jul 10, 2013 | Sale | $8.58 | 1,000 | 8,580 | 176,860 | Jul 12, 2013, 06:57 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Jul 11, 2013 | Sale | $9.32 | 500 | 4,660 | 176,360 | Jul 12, 2013, 06:57 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Jul 12, 2013 | Sale | $10.10 | 5,000 | 50,500 | 171,360 | Jul 12, 2013, 06:57 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Jun 12, 2013 | Sale | $9.08 | 3,000 | 27,250 | 177,860 | Jun 12, 2013, 07:27 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Jun 11, 2013 | Sale | $8.94 | 1,000 | 8,940 | 180,860 | Jun 11, 2013, 07:57 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | May 10, 2013 | Sale | $7.47 | 3,000 | 22,425 | 186,860 | Jun 11, 2013, 07:56 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | May 14, 2013 | Sale | $8.10 | 5,000 | 40,512 | 181,860 | May 16, 2013, 02:28 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | May 10, 2013 | Sale | $7.47 | 3,000 | 22,425 | 186,860 | May 13, 2013, 01:27 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Apr 24, 2013 | Sale | $7.10 | 500 | 3,550 | 189,860 | Apr 26, 2013, 02:40 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Mar 15, 2013 | Sale | $7.10 | 1,500 | 10,650 | 190,360 | Mar 18, 2013, 02:52 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Mar 26, 2012 | Option Exercise | $0.52 | 20,000 | 10,400 | 191,860 | Mar 27, 2012, 07:49 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Oct 11, 2011 | Sale | $6.19 | 500 | 3,095 | 171,860 | Oct 12, 2011, 04:05 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Sep 15, 2011 | Sale | $6.47 | 1,000 | 6,470 | 172,360 | Sep 16, 2011, 02:38 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Aug 11, 2011 | Sale | $7.00 | 200 | 1,400 | 173,660 | Aug 12, 2011, 06:24 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Aug 12, 2011 | Sale | $7.00 | 300 | 2,100 | 173,360 | Aug 12, 2011, 06:24 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Aug 09, 2011 | Sale | $5.96 | 1,000 | 5,964 | 174,660 | Aug 10, 2011, 12:38 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Jul 20, 2011 | Sale | $8.00 | 500 | 4,000 | 174,860 | Jul 21, 2011, 04:44 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Jul 12, 2011 | Sale | $7.23 | 1,500 | 10,846 | 175,360 | Jul 13, 2011, 03:03 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Jun 09, 2011 | Sale | $8.09 | 2,000 | 16,188 | 176,860 | Jun 10, 2011, 04:13 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | May 16, 2011 | Sale | $8.02 | 7,000 | 56,163 | 178,860 | May 17, 2011, 01:45 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | May 12, 2011 | Sale | $7.00 | 1,500 | 10,500 | 185,860 | May 13, 2011, 01:22 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | May 10, 2011 | Sale | $6.02 | 1,000 | 6,018 | 187,360 | May 10, 2011, 07:04 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | May 03, 2011 | Sale | $6.00 | 800 | 4,800 | 188,360 | May 04, 2011, 01:28 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Apr 11, 2011 | Sale | $5.36 | 500 | 2,678 | 189,160 | Apr 12, 2011, 03:41 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Mar 30, 2011 | Sale | $6.00 | 200 | 1,200 | 189,660 | Mar 31, 2011, 08:17 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Mar 09, 2011 | Sale | $5.86 | 500 | 2,930 | 189,860 | Mar 10, 2011, 05:19 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Mar 01, 2011 | Sale | $7.00 | 500 | 3,500 | 190,360 | Mar 03, 2011, 06:50 AM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Feb 18, 2011 | Sale | $6.00 | 500 | 3,000 | 190,860 | Feb 22, 2011, 03:00 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Feb 17, 2011 | Sale | $5.00 | 500 | 2,500 | 191,360 | Feb 22, 2011, 03:00 PM |
Menu